These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32110750)

  • 1. Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates.
    Wallisch M; Lorentz CU; Lakshmanan HHS; Johnson J; Carris MR; Puy C; Gailani D; Hinds MT; McCarty OJT; Gruber A; Tucker EI
    Res Pract Thromb Haemost; 2020 Feb; 4(2):205-216. PubMed ID: 32110750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
    Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
    Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related Thrombosis.
    Kohs TCL; Lorentz CU; Johnson J; Puy C; Olson SR; Shatzel JJ; Gailani D; Hinds MT; Tucker EI; Gruber A; McCarty OJT; Wallisch M
    Cell Mol Bioeng; 2021 Apr; 14(2):161-175. PubMed ID: 33868498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
    Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic zinc is required for factor XII recruitment and activation by stimulated platelets and for thrombus formation in vivo.
    Chaudhry SA; Serrata M; Tomczak L; Higgins S; Ryu J; Laprise D; Enjyoji K; Bekendam R; Kaushik V; Flaumenhaft R; Bendapudi PK
    J Thromb Haemost; 2020 Sep; 18(9):2318-2328. PubMed ID: 32542960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function.
    Liu J; Cooley BC; Akinc A; Butler J; Borodovsky A
    Thromb Res; 2020 Dec; 196():200-205. PubMed ID: 32896690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the contact system in a rabbit model of extracorporeal membrane oxygenation.
    Tweddell JS; Kharnaf M; Zafar F; Riggs KW; Reagor JA; Monia BP; Revenko A; Leino DG; Owens AP; Martin JK; Gourley B; Rosenfeldt L; Palumbo JS
    Blood Adv; 2023 Apr; 7(8):1404-1417. PubMed ID: 36240297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet surface-associated activation and secretion-mediated inhibition of coagulation factor XII.
    Zakharova NV; Artemenko EO; Podoplelova NA; Sveshnikova AN; Demina IA; Ataullakhanov FI; Panteleev MA
    PLoS One; 2015; 10(2):e0116665. PubMed ID: 25688860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.
    Cheng Q; Tucker EI; Pine MS; Sisler I; Matafonov A; Sun MF; White-Adams TC; Smith SA; Hanson SR; McCarty OJ; Renné T; Gruber A; Gailani D
    Blood; 2010 Nov; 116(19):3981-9. PubMed ID: 20634381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo roles of factor XII.
    Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
    Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities.
    Worm M; Köhler EC; Panda R; Long A; Butler LM; Stavrou EX; Nickel KF; Fuchs TA; Renné T
    Ann Transl Med; 2015 Oct; 3(17):247. PubMed ID: 26605293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
    Kleinschnitz C; Stoll G; Bendszus M; Schuh K; Pauer HU; Burfeind P; Renné C; Gailani D; Nieswandt B; Renné T
    J Exp Med; 2006 Mar; 203(3):513-8. PubMed ID: 16533887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
    Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
    J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
    Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
    Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Roles for the Coagulation Factors XI and XII in Regulating the Physical Biology of Fibrin.
    Sylman JL; Daalkhaijav U; Zhang Y; Gray EM; Farhang PA; Chu TT; Zilberman-Rudenko J; Puy C; Tucker EI; Smith SA; Morrissey JH; Walker TW; Nan XL; Gruber A; McCarty OJT
    Ann Biomed Eng; 2017 May; 45(5):1328-1340. PubMed ID: 27933406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in Mice.
    Leung PY; Hurst S; Berny-Lang MA; Verbout NG; Gailani D; Tucker EI; Wang RK; McCarty OJ; Gruber A
    Transl Stroke Res; 2012 Sep; 3(3):381-9. PubMed ID: 23634198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates.
    Gruber A; Harker LA; Hanson SR; Kelly AB; Griffin JH
    Circulation; 1991 Dec; 84(6):2454-62. PubMed ID: 1835678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XII Silencing Using siRNA Prevents Thrombus Formation in a Rat Model of Extracorporeal Life Support.
    Umei N; Shin S; Lai A; Miller J; Roberts K; Strelkova D; Chaudhary N; Ichiba S; Sakamoto A; Whitehead K; Cook K
    ASAIO J; 2023 Jun; 69(6):527-532. PubMed ID: 36728837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a humanized FXII knock-in mouse-A powerful model system to test novel anti-thrombotic agents.
    Beck S; Stegner D; Loroch S; Baig AA; Göb V; Schumbrutzki C; Eilers E; Sickmann A; May F; Nolte MW; Panousis C; Nieswandt B
    J Thromb Haemost; 2021 Nov; 19(11):2835-2840. PubMed ID: 34363738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of platelets in regulating activated coagulation factor XI activity.
    Reitsma SE; Pang J; Raghunathan V; Shatzel JJ; Lorentz CU; Tucker EI; Gruber A; Gailani D; McCarty OJT; Puy C
    Am J Physiol Cell Physiol; 2021 Mar; 320(3):C365-C374. PubMed ID: 33471623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.